GlassScriptPhysician profile
Bryan K Perkins
NPI 1346236551
$3,686.33
in general payments reported to CMS, 2019-2025
41 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $265 · 2021: $498 · 2022: $562 · 2023: $612 · 2024: $424 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $498.69 | 2019-2024 | |
| Hologic Sales and Service, LLC | $347.84 | 2019-2024 | Myosure Tissue Removal Device, Novasure, Coolseal Generator |
| Mayne Pharma Commercial LLC | $327.89 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $289.75 | 2019-2025 | |
| Minerva Surgical, INC | $282.98 | 2019-2020 | |
| Astellas Pharma US INC | $263.93 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $189.78 | 2019-2025 | Slynd |
| Pfizer INC. | $188.51 | 2019-2024 | |
| Coopersurgical, INC. | $181.79 | 2019-2025 | Paragard T 380a, Endosee |
| Myovant Sciences INC. | $126.74 | 2021-2022 | |
| Biogen, INC. | $86.49 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $62.58 | 2019-2022 | |
| Agile Therapeutics, INC. | $53.98 | 2021-2022 | |
| Millicent US INC | $51.84 | 2024-2025 | Intrarosa, Femlyv |
| Coloplast Corp | $51.03 | 2022-2023 | Saffron, Altis |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $49.40 | 2019 | |
| Scynexis, INC. | $47.41 | 2022 | |
| Shield Therapeutics INC | $46.96 | 2023 | Accrufer |
| Novo Nordisk INC | $40.34 | 2024 | Saxenda, Wegovy |
| Axonics, INC. | $38.87 | 2022-2023 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $37.61 | 2023 | Myfembree |
| Medicem INC. | $35.61 | 2021-2023 | |
| Amag Pharmaceuticals, INC. | $34.47 | 2019 | |
| Daiichi Sankyo INC. | $32.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $32.04 | 2024 | |
| Exact Sciences Corporation | $30.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Evofem Biosciences, INC. | $26.10 | 2020-2021 | |
| Duchesnay USA Incorporated | $25.49 | 2019 | |
| Avion Pharmaceuticals | $24.18 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $19.80 | 2019 | |
| Smith+Nephew, INC. | $19.17 | 2019 | |
| Organon LLC | $17.92 | 2021-2025 | Nexplanon |
| Hologic INC | $17.26 | 2019 | |
| Meditrina | $15.08 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.06 | 2019 | |
| Lupin INC. | $14.01 | 2019 | |
| Sanara Medtech INC. | $13.80 | 2021 | |
| Caldera Medical, INC | $13.56 | 2022 | |
| Medtronic, INC. | $12.81 | 2023 | Interstim |
| Asensus Surgical, INC. | $12.21 | 2019 | |
| Mallinckrodt Enterprises LLC | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.